FDA Approves Generic Versions of Lyrica

TRENTON, N.J. (AP) – The U.S. Food and Drug Administration has approved the first generic copies of a popular pill for nerve pain. The agency on Monday said it approved nine generic versions of Pfizer Inc.’s Lyrica. Lyrica, approved in 2004, is Pfizer’s second bestseller, with sales last year of $4.6 billion. While prices can vary widely, the heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. But, according to the drug price comparison website GoodRX, generic versions range from about $140 to $370 per month.